Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Referenceopen allclose all

Endpoint:
basic toxicokinetics, other
Remarks:
toxicokinetics assessment
Type of information:
other: assessment
Adequacy of study:
key study
Study period:
1996
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Objective of study:
toxicokinetics
Qualifier:
no guideline required
Principles of method if other than guideline:
This toxicokinetic assessment is based upon the physico-chemical properties of the test substance, scientific literature and the results of toxicity studies.
GLP compliance:
no
Species:
rat
Sex:
male/female

INFORMATION BASED ON PHYSICO-CHEMICAL PROPERTIES & LITERATURE

The Substance, C34H27N11 011 S3 , has a molecular weight of 861.9 for the free acid, is moderately soluble in water (>27% w/v) and has an estimated log P value of -3.1. The substance also includes a range of minor components, each of which is coloured and represents from 0.1% to 6.1% of the test material. Due to its high molecular weight and log P value, absorption of the intact molecule across the gastrointestinal mucosa would be expected to be both slow and limited. However, the presence of three azo bonds in substance confers the potential for cleavage of the molecule across any one or more of these bonds, particularly by intestinal microorganisms. The various resultant cleavage products would be expected to be more extensively absorbed, well-distributed and subject to further metabolism. Any intact molecule absorbed would similarly be subject to biotransformation; however, its high molecular weight would allow it to be eliminateci via bile, with subsequent excretion in faeces.

Cleavage products of substance may include substituted anilines, which would be subject to ring hydroxylation to produce substituted aminophenols, typically excreted in urine as glucuronide and sulphate conjugates. Alternatively, the amine moiety may be N-acetylated, which would promote urinary excretion, but it may also be metabolised by Noxidation to produce an aryl hydroxylamine, which could be responsible for the mild haemolytic anaemia, observed in the 28 day oral toxicity study.

Alternatively, a larger molecule may be metabolised to forma hydroxylamine metabolite, which could be derived by reduction of the nitrophenyl group.

Cleavage of the substituted naphthalene moiety from the substance would give a very polar metabolite which would be expected to be excreted rapidly in urine. In the remaining part of the cleaved substance molecule, the sulphonamide bridge linking the two aniline rings would be expected to remain intact, giving a metabolite which could be N-acetylated for excretion in urine. Hence, metabolites would be expected to be excreted predominantly in urine, although some high molecular weight conjugates may be eliminateci via bile, for subsequent excretion in faeces, together with

the unabsorbed test substance.

INFORMATION BASED ON TOXICITY STUDIES

The following studies have been considered:

Acute 0ral Toxicity Study in Rats

Acute Dermal Toxicity Study in Rats

Skin Irritation to the Rabbit

Eye Irritation to the Rabbit

Skin Sensitisation to the Guinea Pig

28 Day 0ral Toxicity Study in Rats

Assessment of Mutagenic Potential Using L5178Y Mouse Lymphoma Cells

In the 28 day oral toxicity study, the faeces of rats administered doses of 1000 and 150mg/kg/day were coloured black throughout the study, indicating that the dark brown coloured test substance was extensively eliminateci by this route, probably representing unabsorbed dose. No compound-related effects were seen at the 25 or 150mg/kg dose levels. However, some absorption from the l000mg/kg dose was apparent from histopathological changes in various organs, observations of tissue pigmentation, perturbations in blood clinical chemistry parameters and effects upon the

red blood cells, with reductions in haemoglobin concentration. Increased haemosiderin deposition was also apparent in the spleen, consistent with observations of mild haemolytic anaemia. Plasma alanine and aspartate aminotransferase activities and plasma total bilirubin levels were increased in both sexes, whilst plasma alkaline phosphatase activities were reduced in both sexes. These changes in marker enzyme profiles were consistent with the observations of centrilobular hypertrophy of the liver in almost all rats administered the highest dose level.

No additional toxicokinetic information could be derived from the acute oral study or from any of the dermal or eye studies above.

ABSORPTION, DISTRIBUTION & EXCRETION

The extent of absorption of the test substance cannot be assessed from the above reports, neither can any quantification be applied to excretion, other than to comment that the faeces were intensely coloured, indicating that a significant proportion of the dose was excreted by this route, whereas no discolouration of the urine was apparent.

From observations of widespread tissue pigmentation made during the 28 day oral toxicity study, the absorbed test substance and/or its metabolites were widely distributed. The majority of rats of both sexes had enlarged dark spleens and showed pigmentation of myocardial cells of the heart and in the cortical tubular epithelial cells of the kidney. Some males also showed dark colourations in the brain, epididymis, kidney and liver.

However, some of this colouration may be attributable to coloured impurities in substance orto any coloured metabolites absorbed or formed by biotransformation.

METABOLISM

n the gene mutation assay with L5178Y mouse lymphoma cells, no significant increases in mutant frequency were observed, either in the presence or absence of S9-mix, when tested up to a concentration of 625μg/ml, which represented the limit set by the toxicity of the test sample, therefore, no conclusions can be drawn on the metabolism of the substance from these data.

Conclusions:
The intact substance molecule is likely to be poorly absorbed following oral administration or dermal application, which is consistent with observations of black coloured faeces in both of the oral toxicity studies. However, some cleavage of the substance molecule by intestinal microorganisms would be expected to result in more extensive absorption of the cleavage products, which would be both widely distributed and subject to further metabolism.
The extensive distribution was evident from pigment deposition in various tissues, although this was not associated with any degenerative changes.
In the 28 day oral administration study, symptoms of toxicity were evident only at the top dose level of 1000mg/kg/day, which represented a limit dose for this type of study. The incidence of mild haemolytic anaemia may have been caused by the formation of aryl hydroxylamines, by N-oxidation of substituted anilines, in turn produced by cleavage of the substance molecule.
The incidence of aniline-induced haemolytic anaemia is well-established; however, indications were seen in this 28 day study of a concurrent regenerative process to compensate for the incidence of haemolytic anaemia.
Microsomal enzymes have been shown, in the Ames's test, to possess the capacity to metabolise substance to a mutagenic metabolite.
The excretion of relatively low molecular weight, polar metabolites of substance in urine would be consistent with observations of the absence of any urinary discolouration.
Endpoint:
basic toxicokinetics, other
Remarks:
assessment of the toxicokinetics effects based on acute toxicity tests, long term exposure and reproductive/developmental toxicity test
Type of information:
other: Assessment on existing data
Adequacy of study:
key study
Study period:
May,2011-Novemebr 11, 2011
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The assessment is based on existing data on the potassium and sodium salt of Acid Black 210
Objective of study:
toxicokinetics
Principles of method if other than guideline:
assessment of the toxicokinetics effects based on acute toxicity tests, long term exposure and reproductive/developmental toxicity test
GLP compliance:
no
Species:
rat
Sex:
male/female

The test substance,Acid Black 210, potassium salt was applied to laboratory animals (mouse, rat, rabbit) during studies with different way of entry into organism (e.g. skin, stomach, eye).

Acute toxicity studies - Acid Black 210 - potassium salt

Non toxic for rats after single administration into the stomach. 

Acid Black 210 administered at the dose level of 2000 mg/kg caused no death of animals. No clinical signs of intoxication were observed in all six animals only changes of colour of urine (yellow) was recorded on the following day post treatment accompanied by black-coloured faeces.

No corrosive effects were observed on the skin of rabbit.

Very slight erythema was observed at the 1 hour after 4-hour exposure to the test substance in two animals. At the 24, 48 and 72 hours after exposure no irritation of the skin was observed in all animals. No clinical signs of systemic intoxication were observed.

No corrosive effects were observed on the eye of rabbit.

Slight changes of eye in all rabbitwere observedfrom 1 hour to 48 hours after application. In one rabbit changes persisted till the 5thday after application. 

No clinical signs of systemic intoxication were observed.

Acid black 210 -sodium salt

The test substance is not a contact allergen in mouse.

The test substance, Acid Black 210, did not show a tendency to increase lymph node cell count, lymph node weight and ear weight in mice after application on skin of ears (it confirmed existing dermal irritation data).

 

Conclusion:

The test substance, Acid Black 210– CAS No.: 85223-29-6, was applied to laboratory animals (mouse, rat, rabbit) durin acute studies with different way of entry into organism (oral – by stomach, skin and eye).

The test substance applied to the stomach of the rat elicited no systemic effects.The substance applied on the skin of mouse elicited no effects at the site of application and no systemic toxic effects. The substance applied on the skin of rabbit elicited effects at the site of application that disappeared quickly without systemic toxic effects. The substance when applied to the mucous membrane (conjunctivae) of the rabbit elicited slight effects at the site of application (disappeared until the 6thday) without systemic toxic effects.

Long-term toxicity study - Acid Black 210 - sodium salt

The Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test was performed with the test substance Acid Black 210, sodium salt.

The negative effect on growth of animals (slight decrease of body weight increments, food consumption and food conversion), significant negative effect on some haematological parameters (changes of red and white blood component), some biochemical parameters (changes of AST and ALT activity, creatinine, total cholesterol, phosphorus, and chloride)and biometry of organs (changes of spleen and brain weight)were observed.

The test substance had influence on macroscopical (changes of colour of brain, spleen, thyroid gland, epithelium of thoracic and abdomial cavity, mucosa, skeletal muscle and skin) and microscopical (brown dye in kidneys, spleen, thyroid gland, liver in both sexes and lymph nodes, ovaries in females) structure of organs and tissues.

The test substance treatment affected number of pups, sperm motility, pre-implantation and post-implantation losses.

 

The test substance administration had not adverse effect on mortality, parameters of functional observation and some reproduction parameters - course of mating, pregnancy and lactation, weights of reproductive organs and pituitary gland, spermiogenesis, macroscopical and microscopical structure of reproductive organs and pituitary gland of parental animals, number of post-natal losses of mothers, sex ratio, weight and development of pups.

The test substance, Acid Black 210, after repeated oral application at the highest dose level caused changes of growth of animals (changes of body weight increments, food consumption and conversion),haematological parameters(changes of red and white blood component),biochemical parameters(changes of AST and ALT activity, creatinine, total cholesterol, phosphorus, and chloride) andbiometry of organs(changes of spleen and brain weight).

The test substance had influence on macroscopical and microscopical structure of some organs and tissues (occurrence of pigment in kidneys, spleen, thyroid gland, liver and lymph nodes and ovaries, reversible increased occurrence of extramedular haemopoiesis and enlargement of marginal zone of periarteriolar lymphoid sheaths in spleen).

The test substance treatment affected the number of pups (decrease of the total number of live pups and average number of pups per litter), sperm motility (slower sperm motility), pre-implantation and post-implantation losses (decreased number of corpora lutea, uterus implantations and pups).

The highest incidence of statistically or biologically significant differences was recorded at the highest dose level while most of changes which were found at the middle and the lowest dose level had only mild  intensity without adverse alteration of animal organism.

 

Conclusion:

The results of the Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test with oral administration to the rats showed the negative effect ongrowth of animals, some haematological and some biochemical parameters of the blood, biometry of organs, macroscopical and microscopical structure of some organs and tissues,number of pups, sperm motility, pre-implantation and post-implantation losses.

Acid Black 210 – CAS No.: 85223-29-6 caused toxicological significance irreversible accumulation of pigment in kidneys, spleen, thyroid gland, liver and lymph nodes and ovaries of rats (at the dose level 150 and 450 mg/kg/day) – when it is applied orally.

  

ACCORDING TO THE RESULTS OF LITERATURE DATA

No relevant toxicokinetic references.

 

3.3 ACCORDING TO THE DATABASES DATA

No relevant toxicokinetic references.

Conclusions:
Interpretation of results (migrated information): no bioaccumulation potential based on study results
No systemic effects were described after acute administration of the substance, to rats. The test substance is nontoxic after single administration into the stomach. The substance applied on the skin of mouse elicited no effects at the site of application and no systemic toxic effects. After skin or eye single application systemic toxic effects were not detected. The test substance is probably not absorbed through the stomach, skin or eye after single administration

The systemic effects were described after repeated oral administration of the substance, to rats. The test substance had the negative effect on growth of animals, some haematological and some biochemical parameters of the blood, biometry of organs, macroscopical and microscopical structure of some organs and tissues, number pups, sperm motility, pre-implantation and post-implantation losses only at doses > 150 mg/kg bw7day (NOAEL).
Only at the highest tested dose of 450 mg/Kg bw the substance caused irreversible accumulation of dye in kidneys, spleen, thyroid gland, liver and lymph nodes and ovaries of rats by penetration into the stomach through the blood into different organs.

Executive summary:

Evaluation of toxicokinetics of the substance is required according to the 8.8.1 of Annex VII to the Directive (EC) No. 1907/2006 (REACH). 

Toxicokinetics of the test substance was evaluated from three sources:

-                 Experimental data of toxicological tests

-                 Literary data obtained from internet

-                 Data from toxicological databases – free and commercial     

Experimental toxicological data involved acute toxicity data, long term and reproductive/developmetnal toxicity.

Description of key information

Key value for chemical safety assessment

Additional information

Acid Black 234 is a solid powder odourless, which decomposes before melting at 190°C. Very soluble and with a very low Kow, it is considered not flammable, oxidizing or explosive. Some properties have been considered in read across from similar substance 1, a very similar substance, where a nitro group is missing on the most external part of the molecule.

 

Based on a very extensive literature it is well know that the metabolic pathway of azocompounds passes through the azo-cleavage and therefore the toxicity pattern is strongly bound to the single metabolites coming from the reductive cleavage.

The general behaviour has to be considered regarding also the solubility and distribution of the molecule , time of excretion of the molecule and their real metabolites

In our case the two molecules are very similar and the only difference is in one of the terminal metabolite. All available data at the moment are on similar subsatcne 1 and we will focus singularly on each toxicological end point in order to verify the applicability of Read Across or Weight of Evidence.

 

Phys-chem properties for the two substances are pratically identical (see table below); the missing nitro group can only lower the risk for flammability and explosion, thereforethe experimental results for similar substance 1 can be assumed to be a good evalution also for Acid Black 234.

  Acid Black 234 Similar substance 1
State at 20°C/appearance Black solid odorless powder Black solid odorless powder
Melting point/Boiling Decomposition > 190°C Decomposition > 200°C
Density 1.1932 1.286
Particle size 101.8 um 95.77 um
log Kow -1.86 -1.73
Water solubility 215 g/L 183 g/L

Also from the point of view of biological toxicokinetic, distribution and escretion time the two substances can be considered as equivalent

Based on the evaluation of toxicity data (acute, long term and reproducive+developmental) similar substance 1 shows a low potential for bioaccumulation that can also be applied to Acid Black 234

Two assessements are available for similar substance 1.

In the first assessment, No systemic effects were described after acute administration of Similar substance 1 to rats. The test substance is non toxic after single administration into the stomach.The substance applied on the skin of mouse elicited no effects at the site of application and no systemic toxic effects. After skin or eye single application systemic toxic effects were not detected. The test substance is probably absorbed through the stomach, skin or eye after single administration in a very low amount, not enough to provoque odservable effects. This is true also for Acid black 234, being a molecule of the same size, with the same main functional groups, and with the same phisico chemical properties.

 

The systemic effects were described after repeated oral administration of Similar substance 1 to rats. The test substance had the negative effect on growth of animals, some haematological and some biochemical parameters of the blood, biometry of organs, macroscopical and microscopical structure of some organs and tissues, number of pups, sperm motility, pre-implantation and post-implantation losses only at doses > 150 mg/kg bw/day (NOAEL).

Only at the highest tested dose of 450 mg/Kg bw similar substance 1 caused irreversible accumulation of dye in kidneys, spleen, thyroid gland, liver and lymph nodes and ovaries of rats by penetration from the stomach through the blood into different organs.

To better consider the possibile influence of anyline as metabolite and the impact on the above described end points and the Risk Assessment the following consideration can be taken into account:

In the Registration dossier of anyline the most conservative value for repeated sistemic toxicity is the dermal one, set at 2 mg/Kg bw. This value is far above the most conservative value indicated for the similar substance 1 for any exposure route. It means that considering the tests results of similar substance 1 leds to a conservative Risk Evaluation for Acid Black 234 also.

A special consideration and attention has to be dedicated to the genotoxicity and cancerogenicity end point, where a Risk Evaluation based on conservative doses is not applicable:

To evaluate the influence of anyline as possible metabolite in a high molecular, high hydrophilic polyazo dye, the mutagenicity pattern of Acid Black 001 has been considered. (Colipa opinion B15 - 2010):

Overall, the genotoxicity of Acid Black 1 is sufficiently investigated for the three endpoints of genotoxicity: gene mutations, chromosome aberrations and aneuploidy. Acid Black 1 did induce gene mutations in the first gene mutation tests in bacteria (batch M90114, purity>85%) but not in the second (batch 9405, purity >94.8%), although both tests were performed identically. In the same way in the first mouse lymphoma assay the results obtained with Acid Black 1 were inconclusive (batch M90114, purity >85%) whereas in the second experiment (batch 9405, purity >94.8%) negative results were found. The positive in vitro results for gene mutations were not confirmed in an in vivo unscheduled DNA synthesis test in rats. The induction of chromosome aberrations by Acid Black 1 was only studied in an in vivo micronucleus test with mice; Acid Black 1 exposure did not result in an increase of cells with micronuclei in bone marrow cells. As the positive in vitro results were not confirmed in an in vivo test, Acid Black 1 can be considered to have no in vivo genotoxic potential.

The second assessment confirm that similar substance 1is likely to be poorly absorbed following oral administration or dermal application, which is consistent with observations of black coloured faeces in both of the oral toxicity studies. However, some cleavage of the substance by intestinal microorganisms would be expected to result in more extensive absorption of the cleavage products, which would be both widely distributed and subject to further metabolism.

The extensive distribution was evident from pigment deposition in various tissues, although this was not associated with any degenerative changes.

In the 28 day oral administration study, symptoms of toxicity were evident only at the top dose level of 1000mg/kg/day, which represented a limit dose for this type of study. The incidence of mild haemolytic anaemia may have been caused by the formation of aryl hydroxylamines, by N-oxidation of substituted anilines, in turn produced by cleavage of the substance.

The incidence of aniline-induced haemolytic anaemia is well-established; however, indications were seen in this 28 day study of a concurrent regenerative process to compensate for the incidence of haemolytic anaemia.

The excretion of relatively low molecular weight, polar metabolites of substance in urine would be consistent with observations of the absence of any urinary discolouration.